ArticleJournal of the American Geriatrics Society2025
Screening for Osteoporosis in Nonagenarians: A Scoping Review.
Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Screening for Osteoporosis in Nonagenarians: A Scoping Review.Journal of the American Geriatrics Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs the United States population continues to age and advancements contribute to enhanced life expectancy, care for nonagenarians (adults aged 90 years and older) is as important as ever. A prominent concern within healthcare for the oldest old remains the occurrence of fragility fractures, and subsequent 1-year mortality, making prevention key. As it stands, current guidelines recommend initial screening for all patients aged 65 years or older without further guidance regarding age-related surveillance. The purpose of this scoping review is to better understand the current literature surrounding the benefits and shortcomings of osteoporosis screening and intervention among nonagenarians.
methodsA comprehensive literature search following PRISMA guidelines was conducted using Cochrane, CINAHL, Embase, SCOPUS, Web of Science, and PubMed-MEDLINE from 2018 to present. The search yielded 3346 studies.
resultsTwenty-one articles met inclusion criteria. Common themes were identified among included studies: evaluation of the effectiveness of existing screening guidelines, utility of new osteoporotic screening tools including fracture risk calculators, the role of frailty and multimorbidity in osteoporosis, and reporting of treatment rates and disparities in the management of osteoporosis.
conclusionsOsteoporosis screening and management has been poorly studied within the population of nonagenarians. When caring for the oldest old, there is an apparent discrepancy between current guidelines and clinical decision making. We highlight the need for future research centering on nonagenarians as the primary study group in order to establish factors which should be incorporated into future predictive models and screening recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.